Dual‐Mechanism Suppression of Posterior Capsule Opacification by an MMP2/9‐Responsive Sulforaphane‐Eluting Intraocular Lens

ABSTRACT Posterior capsule opacification (PCO) is the most frequent complication of cataract surgery and is driven by the epithelial‐mesenchymal transition (EMT) of residual lens epithelial cells (LECs). The current standard of care, Nd:YAG laser capsulotomy, is reactive and carries well‐documented complications, underscoring the need for proactive pharmacological prophylaxis. Drug‐eluting intraocular lenses offer a localized delivery platform. Here, we developed a sulforaphane (SFN)‐eluting intraocular lens (GelMA‐SFN@IOL) by integrating SFN‐loaded gelatin methacryloyl (GelMA) microparticles onto the IOL haptics. The GelMA carrier was designed to respond to MMP‐2/9, which were upregulated in PCO‐associated capsular tissues. In vitro, MMP‐2 enhanced SFN release from GelMA‐SFN microparticles, supporting enzyme‐responsive release behavior. In TNFα‐stimulated HLE‐B3 cells, SFN suppressed LEC migration and EMT marker expression, accompanied by increased autophagic activity and reduced MMP‐2/9 expression. These findings suggest a potential feedback mechanism whereby SFN‐mediated MMP downregulation could reduce enzyme‐promoted carrier degradation and release as the pathological signal subsides. In a rabbit PCO model, GelMA‐SFN@IOL preserved capsular clarity and reduced aberrant LEC proliferation over 28 days, with no obvious histological abnormalities in the examined ocular tissues. Together, these results support a proof‐of‐concept strategy combining an enzyme‐responsive carrier with an MMP‐modulating therapeutic for early post‐surgical PCO prevention, with potential for self‐limiting release.

Authors

Institutions

Publication Details

Journal
Advanced Healthcare Materials
Published
2026-11-15
DOI
https://doi.org/10.1002/adhm.71900
Primary Topic
Intraocular Surgery and Lenses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dual‐Mechanism Suppression of Posterior Capsule Opacification by an MMP2/9‐Responsive Sulforaphane‐Eluting Intraocular Lens

Xiu-Hua Wan, Tao Jiang, Jingshang Zhang, Meng Li et al.
Advanced Healthcare Materials
Intraocular Surgery and Lenses
article

Dual‐Mechanism Suppression of Posterior Capsule Opacification by an MMP2/9‐Responsive Sulforaphane‐Eluting Intraocular Lens

Xiu-Hua Wan, Tao Jiang, Jingshang Zhang, Meng Li, Chun-Bo Dong, Jin‐Fei Wei, Hui‐Cong Zheng, Jian‐Ying Liu, Shi‐Chao Zhao, Ying‐Yan Mao
article en

Abstract

ABSTRACT Posterior capsule opacification (PCO) is the most frequent complication of cataract surgery and is driven by the epithelial‐mesenchymal transition (EMT) of residual lens epithelial cells (LECs). The current standard of care, Nd:YAG laser capsulotomy, is reactive and carries well‐documented complications, underscoring the need for proactive pharmacological prophylaxis. Drug‐eluting intraocular lenses offer a localized delivery platform. Here, we developed a sulforaphane (SFN)‐eluting intraocular lens (GelMA‐SFN@IOL) by integrating SFN‐loaded gelatin methacryloyl (GelMA) microparticles onto the IOL haptics. The GelMA carrier was designed to respond to MMP‐2/9, which were upregulated in PCO‐associated capsular tissues. In vitro, MMP‐2 enhanced SFN release from GelMA‐SFN microparticles, supporting enzyme‐responsive release behavior. In TNFα‐stimulated HLE‐B3 cells, SFN suppressed LEC migration and EMT marker expression, accompanied by increased autophagic activity and reduced MMP‐2/9 expression. These findings suggest a potential feedback mechanism whereby SFN‐mediated MMP downregulation could reduce enzyme‐promoted carrier degradation and release as the pathological signal subsides. In a rabbit PCO model, GelMA‐SFN@IOL preserved capsular clarity and reduced aberrant LEC proliferation over 28 days, with no obvious histological abnormalities in the examined ocular tissues. Together, these results support a proof‐of‐concept strategy combining an enzyme‐responsive carrier with an MMP‐modulating therapeutic for early post‐surgical PCO prevention, with potential for self‐limiting release.

Advanced Healthcare Materials
Beijing Tongren Hospital (CN), Capital Medical University (CN), Chinese Academy of Sciences (CN), Beijing Institute of Nanoenergy and Nanosystems (CN), University of Chinese Academy of Sciences (CN)
Intraocular Surgery and Lenses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon